LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: A pictorial atlas

American Journal of Roentgenology

Volumn 203, Issue 1, 2014, Pages

  Jha, Reena C ^a   Mitchell, Donald G ^b   Weinreb, Jeffery C ^c   Santillan, Cynthia S ^d   Yeh, Benjamin M ^e   Francois, Ronald ^a   Sirlin, Claude B ^d  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UCSD MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benign liver nodules; Cirrhosis; Classification of liver lesions; Hepatocellular carcinoma; LI RADS

Indexed keywords

ADULT; AGED; BENIGN LIVER NODULES; CHILD; CLASSIFICATION OF LIVER LESIONS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LI-RADS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; RISK FACTOR; STANDARD;

BENIGN LIVER NODULES; CIRRHOSIS; CLASSIFICATION OF LIVER LESIONS; HEPATOCELLULAR CARCINOMA; LI-RADS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906085264     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.12169     Document Type: Review

References (69)

1. American College of Radiology website. Liver Imaging Reporting and Data System. www.acr.org/Quality-Safety/Resources/LIRADS. Accessed March 21, 2014
2. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. RadioGraphics 2008; 28:747-769
3. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247:311-330
4. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3:573-588 (Pubitemid 37168599)
5. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002; 12:753-764 (Pubitemid 36940129)
6. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020-1022
7. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56:908-943
8. Song P, Tobe RG, Inagaki Y, et al. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int 2012; 32:1053-1063
9. Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 2013; 266:376-382
10. Pomfret EA, Washburn K, Wald C, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16:262-278
11. U.S. Department of Health and Human Services, Organ Procurement and Transplantation website. Policy 9: allocation of livers and liver-intestines. optn.transplant.hrsa.gov/ContentDocuments/OPTN-Policies.pdf. Accessed March 21, 2014
12. Saxena R. Premalignant hepatocellular lesions. In: Practical hepatic pathology: a diagnostic approach. Philadelphia, PA: Elsevier/Saunders, 2011:457-472
13. Baron RL, Campbell WL, Dodd GD III. Peribiliary cysts associated with severe liver disease: imaging-pathologic correlation. AJR 1994; 162:631-636 (Pubitemid 24093567)
14. Dodd GD, Baron RL, Oliver JH 3rd, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. Part II. Focal abnormalities. AJR 1999; 173:1185-1192 (Pubitemid 29493987)
15. Brancatelli G, Federle MP, Blachar A, Grazioli L. Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 2001; 219:69-74 (Pubitemid 32234053)
16. Caturelli E, Pompili M, Bartolucci F, et al. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 2001; 220:337-342 (Pubitemid 32667167)
17. Kamel IR, Liapi E, Fishman EK. Incidental non-neoplastic hypervascular lesions in the noncirrhotic liver: diagnosis with 16-MDCT and 3D CT angiography. AJR 2006; 187:682-687 (Pubitemid 44651490)
18. Lee SJ, Lim JH, Lee WJ, Lim HK, Chao SW, Choo IW. Transient subsegmental hepatic parenchymal enhancement on dynamic CT: a sign of postbiopsy arterioportal shunt. J Comput Assist Tomogr 1997; 21:355-360 (Pubitemid 27212410)
19. Larson AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 2003; 36:149-158 (Pubitemid 36139730)
20. Buscarini E, Plauchu H, Garcia Tsao G, et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 2006; 26:1040-1046 (Pubitemid 44541744)
21. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997; 202:306-314 (Pubitemid 27051716)
22. Schlund JF, Semelka RC, Kettritz U, Eisenberg LB, Lee JK. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient-echo MR images. J Magn Reson Imaging 1995; 5:375-377
23. Ito K, Honjo K, Fujita T, Awaya H, Matsumoto T, Matsunaga N. Hepatic parenchymal hyperperfusion abnormalities detected with multisection dynamic MR imaging: appearance and interpretation. J Magn Reson Imaging 1996; 6:861-867 (Pubitemid 126700839)
24. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (≤2-cm) early enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003; 226:550-555 (Pubitemid 36313448)
25. Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences. Part II. Those not associated with focal lesions. AJR 2007; 188:160-166 (Pubitemid 46012503)
26. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249:G549-G556 (Pubitemid 16235806)
27. Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16:6046-6057
28. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. RadioGraphics 2006; 26:1637-1653
29. Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007; 61:33-43 (Pubitemid 46038027)
30. Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 2005; 237:159-169 (Pubitemid 41346160)
31. Jacobs JE, Birnbaum BA, Shapiro MA, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR 1998; 171:659-664 (Pubitemid 28406126)
32. Venkataraman S, Braga L, Semelka RC. Imaging the fatty liver. Magn Reson Imaging Clin N Am 2002; 10:93-103 (Pubitemid 34205583)
33. Kemper J, Jung G, Poll LW, Jonkmanns C, Lüthen R, Moedder U. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 2002; 27:708-710
34. Brancatelli G, Federle MP, Baron RL, Lagalla R, Midiri M, Vilgrain V. Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging. J Comput Assist Tomogr 2007; 31:116-124 (Pubitemid 46188210)
35. Baron RL, Peterson MS. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging - opportunities and pitfalls. RadioGraphics 2001; 21:S117-S132
36. Dodd GD, Baron RL, Oliver JH 3rd, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. Part I. Gross morphology and diffuse abnormalities. AJR 1999; 173:1031-1036 (Pubitemid 29451308)
37. Ahn IO, de Lange EE. Early hyperenhancement of confluent hepatic fibrosis on dynamic MR imaging. AJR 1998; 171:901-902
38. Choi BI, Lee JM, Han JK. Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging 2004; 29:548-557 (Pubitemid 39095753)
39. Blachar A, Federle MP, Brancatelli G. Hepatic capsular retraction: spectrum of benign and malignant etiologies. Abdom Imaging 2002; 27:690-699 (Pubitemid 36459352)
40. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR 2002; 178:1327-1334 (Pubitemid 34547809)
41. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005; 237:938-944 (Pubitemid 41636384)
42. Kim TK, Chung JW, Han JK, Kim AY, Park JH, Choi BI. Hepatic changes in benign obstruction of the hepatic inferior vena cava: CT findings. AJR 1999; 173:1235-1242 (Pubitemid 29493997)
43. Tublin ME, Towbin AJ, Federle MP, Nalesnik MA. Altered liver morphology after portal vein thrombosis: not always cirrhosis. Dig Dis Sci 2008; 53:2784-2788
44. Vilgrain V, Condat B, Bureau C, et al. Atrophyhypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology 2006; 241:149-155 (Pubitemid 44433345)
45. Lory J, Schweizer W, Blumgart LH, Zimmer-Liver mann A. The pathology of the atrophy/hypertrophy complex (AHC) of the liver: a light microscopic and immunohistochemical study. Histol Histopathol 1994; 9:541-554 (Pubitemid 24234462)
46. Ito K, Mitchell DG, Outwater EK, Blasbalg R. Primary sclerosing cholangitis: MR imaging features. AJR 1999; 172:1527-1533 (Pubitemid 29242332)
47. Okazaki H, Ito K, Fujita T, Koike S, Takano K, Matsunaga N. Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. AJR 2000; 175:1677-1681
48. Dodd GD, Baron RL, Oliver JH, Federle MP. End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 1999; 211:357-362 (Pubitemid 29206801)
49. Bader TR, Beavers KL, Semelka RC. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 2003; 226:675-685 (Pubitemid 36259141)
50. Blachar A, Federle M, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 2001; 220:329-336 (Pubitemid 32667166)
51. Mitchell DG, Palazzo J, Hann HW, et al. Mass-like hepatic hypertrophy: MRI findings with histologic correlation. Magn Reson Imaging 1992; 10:541-547
52. Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR 2002; 178:877-883 (Pubitemid 34250224)
53. Borzio M, Fargion S, Borzio F, et al. Impact of Imaging Reporting and Data System large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003; 39:208-214 (Pubitemid 36920556)
54. Roncalli M. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy-a Western experience. Liver Transpl 2004; 10:S9-S15 (Pubitemid 38240093)
55. Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom Imaging 2000; 25:471-482 (Pubitemid 30659299)
56. Yu JS, Chung JJ, Kim JH, Kim KW. Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications. AJR 2007; 188:1009-1016 (Pubitemid 46496933)
57. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. RadioGraphics 2005; 25:321-331 (Pubitemid 40547048)
58. Krinsky GA, Lee VS, Nguyen MT, et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 2001; 218:47-53 (Pubitemid 32151271)
59. Zhang J, Krinsky GA. Iron-containing nodules of cirrhosis. NMR Biomed 2004; 17:459-464 (Pubitemid 39549423)
60. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology 1999; 212:235-240 (Pubitemid 29302541)
61. Ebara M, Fukuda H, Kojima Y, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999; 210:81-88 (Pubitemid 29004287)
62. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996; 201:207-214 (Pubitemid 26314389)
63. Honda H, Kaneko K, Kanazawa Y, et al. MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 1997; 22:60-66 (Pubitemid 27030218)
64. Mitchell DG, Palazzo J, Hann H, Rifkin MD, Burk DL, Rubin R. Hepatocellular tumors with high signal on T1-weighted MR imaging: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 1991; 15:762-769
65. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 1996; 6:291-294 (Pubitemid 126701457)
66. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178:493-497
67. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005; 11:281-289 (Pubitemid 40458400)
68. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44:7-14 (Pubitemid 44049133)
69. Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 1999; 210:443-450 (Pubitemid 29055314)